By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
DailynewsegyptDailynewsegypt
  • Home
  • Business
    BusinessShow More
    Egypt’s IDA gears up to provide its services for investors online
    Egypt’s IDA gears up to provide its services for investors online 
    March 29, 2023
    Egypt. Germany discuss promotion of cooperation in communications, digital transformation
    Egypt, Germany discuss promotion of cooperation in communications, digital transformation
    March 29, 2023
    Egypt-Australia trade exchange reaches AUD 1bn in FY2022: Ambassador
    Egypt-Australia trade exchange reaches AUD 1bn in FY2022: Ambassador
    March 29, 2023
    Volatile trading on EGX amid anticipation of interest rate movement
    Volatile trading on EGX amid anticipation of interest rate movement
    March 29, 2023
    Mohamed Nasr El-Din appointed as new CEO of Telecom Egypt
    Mohamed Nasr El-Din appointed as new CEO of Telecom Egypt
    March 29, 2023
  • Politics
    PoliticsShow More
    Formes US President Donald Trump Is Indicted in New York
    Trump indicted in hush-money payment case
    March 31, 2023
    Humza Yousaf is to be the first minister of Scotland after narrowly winning the election for leader of the Scottish National Party
    Humza Yousaf becomes Scotland’s first minister: A decade of polls suggest he’ll struggle to deliver independence, just like Nicola Sturgeon
    March 30, 2023
    Iranian FM says Tehran, Moscow taking final step toward signing long-term cooperation agreement
    Iranian FM says Tehran, Moscow taking final step toward signing long-term cooperation agreement
    March 29, 2023
    Health Minister, UNODC discuss bilateral cooperation in combating drugs, corruption
    Health Minister, UNODC discuss bilateral cooperation in combating drugs, corruption
    March 29, 2023
    UAE President appoints Khaled bin Mohamed bin Zayed as Crown Prince of Abu Dhabi
    UAE President appoints Khaled bin Mohamed bin Zayed as Crown Prince of Abu Dhabi
    March 29, 2023
  • Interviews
    InterviewsShow More
    Developers have to offer innovative products, state should provide more facilities to stimulate industry: Kareem Mamoun
    Developers have to offer innovative products, state should provide more facilities to stimulate industry: Kareem Mamoun
    March 27, 2023
    Government should help Egyptian arts revive its pioneering role: Omar Abdel Aziz
    Government should help Egyptian arts revive its pioneering role: Omar Abdel Aziz
    March 15, 2023
    Interconnected healthcare systems in Africa require political will from North African leaders: Amref official
    Interconnected healthcare systems in Africa require political will from North African leaders: Amref official
    March 12, 2023
    EGX ready for government’s IPOs programme: Chairperson
    EGX ready for government’s IPOs programme: Chairperson
    February 15, 2023
    British International Investment invests $4.5bn in 700 businesses across Africa: Sherine Shohdy
    February 15, 2023
  • Culture
  • Opinion
  • Sports
  • Lifestyle
Reading: Novartis Egypt launches 2 new products for asthma patients
Share
Notification
Latest News
Formes US President Donald Trump Is Indicted in New York
Trump indicted in hush-money payment case
Politics
Humza Yousaf is to be the first minister of Scotland after narrowly winning the election for leader of the Scottish National Party
Humza Yousaf becomes Scotland’s first minister: A decade of polls suggest he’ll struggle to deliver independence, just like Nicola Sturgeon
Politics Opinion
Egypt’s IDA gears up to provide its services for investors online
Egypt’s IDA gears up to provide its services for investors online 
Business
Iranian FM says Tehran, Moscow taking final step toward signing long-term cooperation agreement
Iranian FM says Tehran, Moscow taking final step toward signing long-term cooperation agreement
Politics World
Egypt. Germany discuss promotion of cooperation in communications, digital transformation
Egypt, Germany discuss promotion of cooperation in communications, digital transformation
Business
Aa
Aa
DailynewsegyptDailynewsegypt
  • Home
  • Business
  • Politics
  • Interviews
  • Culture
  • Opinion
  • Sports
  • Lifestyle
  • Home
  • Business
  • Politics
  • Interviews
  • Culture
  • Opinion
  • Sports
  • Lifestyle
Have an existing account? Sign In
Follow US
  • Advertise
© 2023 DNE News. All Rights Reserved.
Dailynewsegypt > Blog > Health > Novartis Egypt launches 2 new products for asthma patients
HealthPolitics

Novartis Egypt launches 2 new products for asthma patients

Daily News Egypt
Last updated: 2022/04/22 at 3:26 PM
By Daily News Egypt 6 Min Read
Share
Novartis Egypt launches 2 new products for asthma patients with fixed-dose combination triple therapy in one device for asthma in Egypt
SHARE

Novartis Pharma S.A.E. (Novartis Egypt) held a press conference to announce the introduction of the first fixed dose combination triple therapy in one device for asthma in Egypt, with the goal of offering patients better control of their condition and improving their quality of life. Renowned respiratory and pulmonology experts were invited to discuss the patient journey in Egypt, advances in therapies for uncontrolled asthma and the benefits of modern inhalers in promoting greater treatment adherence.
“Asthma is the most prevalent chronic respiratory disease in the world, with a substantial health and economic impact on patients. Around 358 million people worldwide suffered from asthma in 2015, causing 400,000 deaths1.,” Dr. Mohamed Awad Tageldin, Professor of Pulmonology at Ain Shams University, said.

“Fewer patients self-rate their asthma as uncontrolled compared to those who are truly uncontrolled. Half of asthma patients are poorly adherent to therapeutic advice which may lead to asthma exacerbations and hospitalizations. A study conducted in 2020 evaluated asthmatic patients’ adherence to inhaler therapy and sought to examine drug-related factors affecting it among Egyptian asthma patients. The study showed that out of 110 patients, 42.2% demonstrated a high level, 22.9% a medium level, and 34.9% a low level of medication adherence.” (22,23,24,25)Dr. Tarek Safwat, Professor of Pulmonology at Ain Shams University said.

“Risk factors for asthma have been determined to be age, gender, country as well as specific comorbidities such as respiratory, cardiovascular, gastrointestinal, nervous, and neurological diseases. More than 1/3 of patients remain uncontrolled when treated with current inhalers. A considerable percentage of patients (28-68%) do not use the inhalers correctly, reducing medication benefits,”(22,24,25) Dr. Hossam Hosny, Professor of Pulmonology at Cairo University said.

Achieving higher rates of adherence requires research to determine the current weak points and counteract them to support patients. The PLATINUM program was designed with that purpose in mind. The program enrolled over 7,500 patients worldwide. The 4 studies in Platinum program showed that the main concern is the poor adherence to inhaler therapy in patients with bronchial asthma is the fact that it increases mortality, morbidity, and the number of hospital visits and leads to higher healthcare costs for patients. It is essential to try and increase medication adherence so that patients can obtain the greatest benefits possible from this form of therapy,15,26,27,28,29” Dr. Essam Gouda, Professor of Pulmonology at Alexandria University, said.

“The first fixed dose combination triple therapy in one device in Egypt is very positive news for patients. These new products have demonstrated their capacity to provide better quality of life and reduce exacerbations compared to the standard of care significantly, with 19% improvement for dual therapy and 43% for triple therapy introduction of new inhalers with new molecules in Egyptian Market in both dual and triple therapy inhalers: Mometasone fuorate has demonstrated the highest binding affinity with superior control, 26,27,28,29” Dr. Adel Khatab, Professor of Pulmonology at Ain Shams University said.

Patient compliance on one device will serve both patients and environment as patients would not require extra reliever treatments in pMDI, which subsequently decreases emissions and carbon footprint, 26,27,28,29” Dr Khatab added.

“The treatments currently available to asthma patients have been able to help them cope with their condition, but many experience exacerbations of their disease and symptoms, which significantly impacts their quality of life. At Novartis, our goal is to reimagine asthma care in a way that helps patients better control their disease. Over the last 60 years, there have been two major breakthroughs in asthma care at Novartis, the first was inhalers in the 1960s and more recently the development of biologics. The introduction of fixed dose combination triple therapy in one device for asthma in Egypt is a testament to our commitment to local patients and to ensuring that they have access to the latest breakthroughs in treatment,” Dr. Gehan Ramadan, Novartis Egypt Chief Scientific Officer, said.
“At Novartis, we seek to develop solutions for both widespread and rare diseases. Respiratory diseases, and asthma in particular, with their high prevalence rates, have been a top priority for Novartis for many years. We take our role as a leading respiratory company very seriously, and our focus is on driving novel advances to improve the lives of those living with lung conditions all around the world. By prioritizing innovation and establishing close partnerships with patients and medical experts, Novartis hopes to solve the unmet needs in asthma management, improving treatment outcomes for asthma and other respiratory diseases and relieving the burden such conditions place on the healthcare sector and society as a whole,” Ahmed Magdy Taher, Head of Immunology, Dermatology and Respiratory Franchise at Novartis Egypt said.

You Might Also Like

Trump indicted in hush-money payment case

Humza Yousaf becomes Scotland’s first minister: A decade of polls suggest he’ll struggle to deliver independence, just like Nicola Sturgeon

Iranian FM says Tehran, Moscow taking final step toward signing long-term cooperation agreement

Health Minister, UNODC discuss bilateral cooperation in combating drugs, corruption

UAE President appoints Khaled bin Mohamed bin Zayed as Crown Prince of Abu Dhabi

TAGGED: Novartis Egypt
Share this Article
Facebook Twitter Email Print
Previous Article First Abu Dhabi Bank withdraws its bid to acquire Hermes
Next Article Egypt, Germany celebrate 70th anniversary of establishment of diplomatic relations
Ad image

Stay Connected

Facebook Like
Twitter Follow
Instagram Follow
Youtube Subscribe

Latest News

Formes US President Donald Trump Is Indicted in New York
Trump indicted in hush-money payment case
Politics
Humza Yousaf is to be the first minister of Scotland after narrowly winning the election for leader of the Scottish National Party
Humza Yousaf becomes Scotland’s first minister: A decade of polls suggest he’ll struggle to deliver independence, just like Nicola Sturgeon
Politics Opinion
Egypt’s IDA gears up to provide its services for investors online
Egypt’s IDA gears up to provide its services for investors online 
Business
Iranian FM says Tehran, Moscow taking final step toward signing long-term cooperation agreement
Iranian FM says Tehran, Moscow taking final step toward signing long-term cooperation agreement
Politics World
//
Egypt’s only independent daily newspaper in English. Discuss the country’s latest with the paper’s reporters, editors, and other readers.

Quick Link

  • Home
  • Business
  • Politics
  • Interviews
  • Culture
  • Opinion
  • Sports
  • Lifestyle

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

© 2023 DNE News. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc..

Zero spam, Unsubscribe at any time.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?